Glycogen synthase kinase-3 controls IL-10 expression in CD4(+) effector T-cell subsets through epigenetic modification of the IL-10 promoter. (2015)

First Author: Hill EV
Attributed to:  Targeting GSK-3 in antigen-specific immunotherapy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/eji.201444661

PubMed Identifier: 25627813

Publication URI: http://europepmc.org/abstract/MED/25627813

Type: Journal Article/Review

Volume: 45

Parent Publication: European journal of immunology

Issue: 4

ISSN: 0014-2980